The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time  by Hoy, Wendy E. et al.
Kidney International, Vol. 60 (2001), pp. 243–248
The natural history of renal disease in Australian Aborigines.
Part 1. Changes in albuminuria and glomerular
filtration rate over time
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metabolic profile of the entire community and reducing infec-The natural history of renal disease in Australian Aborigines.
tions. Modification of the course in people with establishedPart 1. Changes in albuminuria and glomerular filtration rate
disease depends on vigorous control of blood pressure and theover time.
metabolic profile and the specific use of angiotensin-convertingBackground. The purpose of this study was to describe changes
enzyme inhibitors.over time in albuminuria and glomerular filtration rate (GFR)
in a cohort of Australian Aborigines from a community with
high rates of renal disease and renal failure.
Methods. Participants were 486 adult community members Aborigines in the remote areas of Australia are experi-(20 years at first exam) who were screened for renal disease
encing an epidemic of renal disease and renal failureand related factors on at least two occasions (mean 2.7 occa-
[1, 2]. Albuminuria is common, and renal biopsies, whilesions), at least a year apart, between 1990 and 1997. Renal
function was assessed by the albumin:creatinine ratio (ACR; including all of the usual pathologies, are remarkable
g/mol) on a random urine specimen and by the GFR estimated for the high proportion with distinctly enlarged glomeruli
from the Cockcroft-Gault formula. Evolution over time was and variable degrees of sclerosis (abstract; Howard etexpressed as the average annual changes in these parameters.
al, Aust NZ Soc Nephrol 1996) [3, 4].Results. On baseline examination, 70% of participants had
We have already described a community-based studyalbuminuria (ACR 1.1 g/mol) There was a significant net
increase in ACR and a fall in GFR in the cohort over time. in one high-risk group, with a recent end-stage renal dis-
Among individuals, however, changes were strongly correlated ease incidence of 2700 per million [5–7]. Albuminuria
with ACR levels at baseline. There was no loss of GFR in was pervasive, and (on cross-sectional study) increasedpersons with normal renal parameters at baseline and a rapid
with increasing age. The level of albuminuria was alsoloss of GFR in those with substantial levels of albuminuria at
significantly correlated with body mass index (BMI),baseline. Other factors significantly correlated with progression
of ACR included age, baseline body mass index and systolic blood pressure, glucose and lipid levels, heavy drinking,
blood pressure, the presence of diabetes (or levels of fasting the presence of scabies, a history of poststreptococcal
glucose), and elevated levels of serum gamma glutamyl trans- glomerulonephritis, the presence of hematuria, and in-ferase. Factors significantly associated with loss of GFR in-
versely with birth weight. Average GFR values werecluded body mass index, diabetes, systolic and diastolic blood
slightly higher in persons with subtle levels of pathologicpressures, microscopic hematuria, and marginally high choles-
terol levels. albuminuria than in those with normal albumin excretion
Conclusion. Albuminuria progresses and GFR is lost over and then, beginning in the midmicroalbuminuria range,
time in individuals in this community, at rates that are strongly were progressively lower as levels of albuminuria in-dependent on levels of pre-existing albuminuria. Much loss of
creased further [8].GFR and all renal failure should be avoided by preventing the
The increase in ACR and serum creatinine with in-development of albuminuria and minimizing its progression.
This depends on improving the weight, blood pressure, and creasing age on this cross-sectional view could represent
progression in individuals over time and/or a cohort phe-
nomenon. These have different implications for futureKey words: kidney failure in Aborigines, end-stage renal disease, pro-
disease rates. The current report describes the longitudi-gressive renal disease, death and GFR, albuminuria, epidemic of kidney
disease, hypertension, obesity, metabolic profile. nal evolution of ACR and GFR in adults in this commu-
nity and their determinants. We have already describedReceived for publication August 30, 2000
the implications of albuminuria and GFR for renal fail-and in revised form December 27, 2000
Accepted for publication January 30, 2001 ure and natural death [9], and further develop that theme
in an accompanying article in this issue [10]. 2001 by the International Society of Nephrology
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Table 2. Renal status of participants at baseline examinationTable 1. Characteristics of participants at baseline exam
Parameter Baseline value Parameter Baseline value
ACR g/mol g mean (95% CI) 4.7 (3.9–5.5)Female/male 45%/55%
Age years 34.3 (11.7) ACR category
1.1 145/486, 29.8%BMI kg/m2 23.4 (5.1)
SBP mm Hg 123 (18) 1.1–3.3 83/486, 17.1%
3.4–33 153/486, 31.5%DBP mm Hg 75 (13)
Diabetes 51/486, 10.5% 34–99 75/486, 15.4%
100–199 21/486, 4.3%Cholesterol 5.5 mmol/L 84/463, 18.1%
GGT40 U/L for females 200 9/486, 1.9%
Serum creatinine umol/L, mean (SD) 85 (23)60 IU/L for males 114/465, 24.5%
Estimated GFR mL/min/1.73 m2, mean (SD) 97.1 (24.2)Data are mean (SD) or proportion. Abbreviations are: BMI, body mass index;
Hematuria 1 on dipstick 92/481, 19.1%SBP, systolic blood pressure; DBP, diastolic blood pressure; GGT, gamma gluta-
myl transferase. Abbreviations are: ACR, albumin:creatinine ratio; GFR, glomerular filtration
rate.
METHODS
dichotomous variables with changes in ACR and GFR
All members of this remote Aboriginal community
were evaluated by two-tailed t tests. All analyses were
were invited to participate in a renal disease screening
performed using Stata Statistical software [14].
program conducted between 1990 and 1997. The study
cohort consisted of people who were age 20 years at
their first examination and were screened on at least two RESULTS
separate occasions at least one year apart, with a full set Four hundred eighty-six people qualified for inclusion.
of observations on each occasion, before the institution They were followed for 1 to 6 years, with a mean of 3.9
of systematic antihypertensive/renal protective treat- years. They underwent a mean of 2.7 examinations at
ment, death, dialysis, or the close-out of the study in least a year apart; 195 people had two examinations,
April 1998. and 291 had three or more examinations. These people
Height, weight, and blood pressure were measured, and represent 63% of adults who were screened at least once
skin was examined for sores and scabies. The urinary albu- in the program with a full set of observations (N  776)
min:creatinine ratio (ACR g/mol) was measured on a and approximately 57% of the entire adult community
random urine specimen using the Beckman radioimmuno- (N  850).
assay for albumin determinations. The following catego- Table 1 summarizes the characteristics of participants
ries of ACR were employed for the analyses: ACR1.1 at baseline exam; 268 were male and 218 were female.
normal; ACR 1.1 to 3.3  suspicious; ACR 3.4 to 33  Their age at first exam ranged from 20 to 76 years (mean
microalbuminuria; and ACR 34  overt albuminuria 34.3 years). Fifty-one (10.5%) were diabetic at time of
[5]. People with overt albuminuria were further subdi- baseline exam.
vided into those with ACR 34 to 99, ACR 100 to 199, Table 2 summarizes the renal status of participants at
and ACR 200. Serum creatinine was measured, and baseline examination. Albuminuria was common, with
glomerular filtration rate (GFR) was estimated by the a group mean well above the upper limit of normal of
Cockcroft-Gault formula [11]. Persons were considered 1.0 g/mol. Only 29.8% of persons had normal ACRs,
to be diabetic if this diagnosis already existed or if a ran- while 31.5% had microalbuminuria and 21.6% had overt
dom blood glucose or a two-hour postglucose challenge albuminuria. Average serum creatinine was “normal,”
blood glucose level exceeded 11 mmol/L [12]. Fasting but there was a wide variation. Average GFR was less
glucose levels were measured in 249 of the 486 people than 100 mL/min/1.73 m2. Nineteen percent of people
on the first examination. Levels of cholesterol and serum had microscopic hematuria. All these findings were simi-
gamma glutamyl transferase (GGT) were also measured. lar to those of people who were not included in the
In persons who had only two visits (N  195), the longitudinal cohort [6].
average annual change in ACR (GFR) was calculated Figure 1 shows the correlation between estimated GFR
as follows: ACR  (last ACR  first ACR)/time be- and ACR values at baseline. It hints at higher GFRs in
tween first and second visits. For people who had more people with subtle levels of pathologic albuminuria and
than two visits, single linear regression coefficients were shows progressively lower GFRs in people with increas-
used to estimate the average annual change in ACR and ing intensity of pathologic albuminuria thereafter.
GFR [13]. The association of continuous variables with Table 3 shows the average annualized changes in clini-
change in ACR (not normally distributed) was evaluated cal parameters over time in the entire group. There were
by nonparametric Spearman analysis, and correlations significant net increases in weight, body mass index (BMI),
with changes in GFR, which were normally distributed, and blood pressure, as well as ACR and serum creati-
nine, and GFR decreased significantly.were analyzed by linear regression. The associations of
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Fig. 2. Average annual change in ACR by baseline ACR category.
Fig. 1. Estimated glomerular filtration rate (GFR) at baseline (mL/
min/1.73 m2) by the albumin:creatinine ratio (ACR) at baseline.
Table 3. Average annual change in clinical characteristics
in 486 participants
Annual change
Variable mean (SD) P
Weight kg 0.52 (1.93) 0.0001
BMI kg/m2 0.22 (.78) 0.0001
SBP mm Hg 0.96 (7.0) 0.0026
DBP mm Hg 0.51 (4.8) 0.0195
ACR
g/mol, mean 4.46 (22.1) 0.0001
g mean 1.10 (1.46)
Serum creatinine lmol/L 3.02 (20.2) 0.0011
Estimated GFR mL/min 1.14 (4.82) 0.0001
Estimated GFR mL/min/1.73 m2 1.41 (5.75) 0.0001
Abbreviations are: BMI, body mass index; ACR, albumin:creatinine ratio;
Fig. 3. Annual change in estimated GFR (mL/min/1.73 m2) by ACRSBP, systolic blood pressure; DBP, diastolic blood pressure; GFR, glomerular
filtration rate. at baseline.
nual change in ACR was very small and varied little inChanges in ACR and GFR were quite variable. Fig-
ures 2 and 3 demonstrate their relationship with baseline people with normal ACR values at baseline; it was posi-
tive in people with pathologic albuminuria at baseline,ACR on a continuum. There was little change in ACR
in people with normal ACR values at baseline and there increasing as the level of baseline albuminuria rose, and
then appeared to fall at extreme baseline levels of overtwas increasing annual net change in ACR, both positive
and negative, with increasing levels of pathologic albu- albuminuria. There was an apparent net increase in GFR
among people with normal and suspicious levels of ACRminuria at baseline. There were wide variations in change
of GFR at all levels of baseline ACR, but the line of best at baseline. Then there was a consistent decrease in GFR
with increasing levels of pathologic levels of albuminuriafit suggests that, on average, GFR was stable or increased
slightly in people with subtle levels of albuminuria and at baseline; this was already clear in persons with micro-
albuminuria, who on average were losing an average ofthen began to fall in people with increasing levels of patho-
logic albuminuria, starting in the early to midmicro- 2.2 mL/min/year of GFR, and culminated in an average
loss of 11.6 mL/min/year in those with ACR 200 at firstalbuminuria range; this fall became quite dramatic at
higher levels of overt albuminuria at baseline. observation. Average annual changes in serum creati-
nine, which do not reflect interim changes in weight andFigure 4 summarizes the net changes in ACR and GFR
changes by category of baseline ACR. The average an- age, confirmed these trends.
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Table 4. Factors at baseline correlating with annual changes
in albumin:creatinine ratio (ACR) (g/mol)
Variable Coefficient, P
Age years 0.18, 0.001
ACR g/mol 0.18, 0.001
BMI kg/m2 0.23, 0.001
SBP mm Hg 0.11, 0.01
Fasting glucose mmol/La 0.16, 0.012
Diabetes y/n 6.75, 0.001
High GGT y/n 2.63, 0.03
Abbreviations are: BMI, body mass index; SBP, systolic blood pressure; GGT,
gamma glutamyl transferase.
a Fasting glucose measured on only 249 of the 486 people
Table 5. Factors at baseline correlating with annual changes
in glomerular filtration rate (GFR) (mL/min/1.73 m2)
Coefficient, P
Coefficient, P adjusted for
Variable unadjusted baseline ACR
ACR g/mol 0.30, 0.001 —
BMI kg/m2 0.22, 0.001 0.13, 0.009
SBP mm Hg 0.05, 0.001 0.018, 0.19
DBP mm Hg 0.07, 0.001 0.017, 0.39
Fasting glucose mmol/La 0.46, 0.003 0.20, 0.23
Diabetes 3.35, 0.001 1.08, 0.21
Hematuria 1.96, 0.003 0.93, 0.14
High cholesterol 1.25, 0.06 0.64, 0.92
Female 0.89, 0.09 0.81, 0.10
Abbreviations are: ACR, albumin:creatinine ratio; BMI, body mass index;
SBP, systolic blood pressure; DBP, diastolic blood pressure.
a Fasting glucose measured on only 249 of the 486 people
Table 5 shows factors that correlated significantly with
a loss of GFR in univariate analysis. These included base-
line ACR, BMI, SBP, DBP, fasting glucose, diabetes, the
presence of hematuria, and marginally, high cholesterol
levels. Females tended to have higher rates of loss of
Fig. 4. Annual changes in albumin:creatinine ratio (ACR) (A) and GFR, but the association was not significant.average annual changes in glomerular filtration rate (GFR) (B) by
In multivariate analysis, factors that were significantbaseline ACR category. Data are mean  SE.
(P  0.10) in the final model of change in GFR included
baseline ACR, age, SBP, female sex, and BMI; thus:
 GFR  5.53  0.848 lnACR (CI 1.13, 0.56, P  0.001)There were no consistent correlations between annual
changes in ACR or GFR themselves.  0.059 age (CI 0.012, 0.106, P  0.014)
Table 4 shows factors that on univariate analysis were
 0.034 SBP (CI 0.064, 0.003, P  0.033)significantly correlated with increase in ACR. In nonpar-
ametric analysis, continuous variables that were signifi-  1.001 female sex (CI 2.06, 0.06, P  0.064)
cantly correlated with increase in ACR included baseline
 0.087 BMI (CI 0.188, 0.14, P  0.094)ACR, age, BMI, systolic blood pressure (SBP), fasting
glucose levels, diabetes, and high GGT levels. The appar- In most models, 75% of the explained variance in
ently facilitating effect of female sex (coefficient 1.96, GFR was carried by baseline ACR.
P 0.14) and diastolic blood pressure (DBP; coefficient
0.07, P  0.15) did not reach significance, and elevated
DISCUSSIONcholesterol levels (P  0.34) and hematuria (P  0.31)
were not significant determinants. Renal disease progressed over time in adults in this
community. There was a net progression of albuminuriaThe distribution of changes in ACR could not be nor-
malized, so multivariate models could not be derived. and loss of GFR over time, although individual changes
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varied. There was little change in albuminuria in people independent markers of renal damage. Our data suggest,
however, that interventions that suppress the develop-with normal levels at baseline, a net increase in those
ment or increase of albuminuria will avoid renal insuffi-with mild and moderate pre-existing albuminuria, and a
ciency or retard its progression.net fall in those with heavy pre-existing levels, which
Prevention involves improvement of the entire com-probably reflects the loss of filtering surface as disease
munity health profile to reduce risk factors for renal dis-progresses. Loss of GFR was critically dependent on
ease expression and progression. This includes contain-pre-existing levels of albuminuria. There was no measur-
ment of adult weight, blood pressure, and blood glucoseable loss over a year in persons without pathologic albu-
levels, which all increase inexorably through middle lifeminuria at baseline, a significant loss in people with
[5], and a reduction in infections. In an environment inmicroalbuminuria at baseline (mean 2.1 mL/min/year),
which a multitude of different risk factors of high preva-and an average loss of GFR of almost 12 mL/min/year
lence are operating, “ideal” levels of each of these parame-in people with ACR 200 at baseline. Thus, levels of
ters might be lower than “normal” in other populations.albuminuria predict loss of renal function. As we de-
For people with normal renal function, good health mightscribe elsewhere [9, 10], they also powerfully predict
be sustained over a reasonable period by minimizingrenal failure, as well as natural death.
these factors. For people with established disease, theseOther factors correlated with progression of albumin-
same interventions should be beneficial, with medicaluria and/or loss of GFR include female sex, age, BMI,
modifications of blood glucose levels, blood pressures,diabetes, or increasing blood glucose, blood pressure,
and lipids added as needed. In addition, angiotensin-microscopic hematuria, high GGT levels, and perhaps
converting enzyme inhibitors appear to confer additionalcholesterol levels. These factors also correlate with inten-
extrarenal protection [23–31].sity of albuminuria on cross-sectional study of this popu-
While our results illuminate the relationship betweenlation [6] and indicate target areas for interventions. The
pathologic albuminuria and loss of GFR, they might alsocorrelation of increasing BMI with increasing ACR and
be exposing different events early in the evolution ofloss of GFR emphasizes the important effect of adult
renal disease. The increase in mean GFR over time inweight on renal disease [5, 6, 15]. The predictive value of
persons with ACR 1.1 g/mol and the fact that meanhematuria for progression might reflect an inflammatory
GFR is highest in people with early to midrange micro-element in the primary process, possibly related to skin
albuminuria on the cross-sectional data might be hintinginfections and poststreptococcal glomerulonephritis [6].
at hyperperfusion/hyperfiltration early in the diseaseIt might also reflect structural damage associated with
course. This process, well recognized in early diabeticadvancing disease.
nephropathy [32], might thus be generalizable to theSeveral reports describe the predictive value of albu-
broader spectrum of renal disease and provide a pointminuria (proteinuria) for loss of GFR in people with
for intervention at a much earlier stage [25, 29].obvious renal disease, usually studied in nephrology
practices [16–22]. We describe this relationship at a com- ACKNOWLEDGMENTS
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